Cargando…

Forkhead Box Transcription Factors: Double-Edged Swords in Cancer

A plethora of treatment options exist for cancer therapeutics, but many are limited by side effects and either intrinsic or acquired resistance. The need for more effective targeted cancer treatment has led to the focus on forkhead box (FOX) transcription factors as possible drug targets. Forkhead f...

Descripción completa

Detalles Bibliográficos
Autores principales: Castaneda, Maria, den Hollander, Petra, Mani, Sendurai A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258984/
https://www.ncbi.nlm.nih.gov/pubmed/35315926
http://dx.doi.org/10.1158/0008-5472.CAN-21-3371
_version_ 1784741671527776256
author Castaneda, Maria
den Hollander, Petra
Mani, Sendurai A.
author_facet Castaneda, Maria
den Hollander, Petra
Mani, Sendurai A.
author_sort Castaneda, Maria
collection PubMed
description A plethora of treatment options exist for cancer therapeutics, but many are limited by side effects and either intrinsic or acquired resistance. The need for more effective targeted cancer treatment has led to the focus on forkhead box (FOX) transcription factors as possible drug targets. Forkhead factors such as FOXA1 and FOXM1 are involved in hormone regulation, immune system modulation, and disease progression through their regulation of the epithelial–mesenchymal transition. Forkhead factors can influence cancer development, progression, metastasis, and drug resistance. In this review, we discuss the various roles of forkhead factors in biological processes that support cancer as well as their function as pioneering factors and their potential as targetable transcription factors in the fight against cancer.
format Online
Article
Text
id pubmed-9258984
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Association for Cancer Research
record_format MEDLINE/PubMed
spelling pubmed-92589842022-12-06 Forkhead Box Transcription Factors: Double-Edged Swords in Cancer Castaneda, Maria den Hollander, Petra Mani, Sendurai A. Cancer Res Reviews A plethora of treatment options exist for cancer therapeutics, but many are limited by side effects and either intrinsic or acquired resistance. The need for more effective targeted cancer treatment has led to the focus on forkhead box (FOX) transcription factors as possible drug targets. Forkhead factors such as FOXA1 and FOXM1 are involved in hormone regulation, immune system modulation, and disease progression through their regulation of the epithelial–mesenchymal transition. Forkhead factors can influence cancer development, progression, metastasis, and drug resistance. In this review, we discuss the various roles of forkhead factors in biological processes that support cancer as well as their function as pioneering factors and their potential as targetable transcription factors in the fight against cancer. American Association for Cancer Research 2022-06-06 2022-03-22 /pmc/articles/PMC9258984/ /pubmed/35315926 http://dx.doi.org/10.1158/0008-5472.CAN-21-3371 Text en ©2022 The Authors; Published by the American Association for Cancer Research https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs International 4.0 License.
spellingShingle Reviews
Castaneda, Maria
den Hollander, Petra
Mani, Sendurai A.
Forkhead Box Transcription Factors: Double-Edged Swords in Cancer
title Forkhead Box Transcription Factors: Double-Edged Swords in Cancer
title_full Forkhead Box Transcription Factors: Double-Edged Swords in Cancer
title_fullStr Forkhead Box Transcription Factors: Double-Edged Swords in Cancer
title_full_unstemmed Forkhead Box Transcription Factors: Double-Edged Swords in Cancer
title_short Forkhead Box Transcription Factors: Double-Edged Swords in Cancer
title_sort forkhead box transcription factors: double-edged swords in cancer
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258984/
https://www.ncbi.nlm.nih.gov/pubmed/35315926
http://dx.doi.org/10.1158/0008-5472.CAN-21-3371
work_keys_str_mv AT castanedamaria forkheadboxtranscriptionfactorsdoubleedgedswordsincancer
AT denhollanderpetra forkheadboxtranscriptionfactorsdoubleedgedswordsincancer
AT manisenduraia forkheadboxtranscriptionfactorsdoubleedgedswordsincancer